Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Comparative and Functional Genomics
|
July 17, 2008
C(2)M: configurable chemical middleware
P van der Vet, H E Roosendaal, P A Geurts
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
May 1, 1988
Once daily Theo-Dur in morning dippers
A P van der Vet, M Quaedvlieg, L H Greve
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
August 1, 1984
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels
A P van der Vet, R H Drost, J Kreukniet, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
July 1, 1985
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function
A P van der Vet, J Kreukniet, R H Drost, et al.
European Journal of Respiratory Diseases. Supplement
|
January 1, 1984
Alpha 2-adrenergic receptors on intact human platelets of normal individuals and chronic obstructive lung disease patients
P L Bruynzeel, M L Hamelink, P T Kok, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1986
Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis
A P van der Vet, J Kreukniet, R H Drost, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
November 1, 1987
Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement
A P van der Vet, J Kreukniet, R H Drost, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
November 1, 1986
Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo
A P Van der Vet, J Kreukniet, R H Drost, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1987
Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis
A P van der Vet, J Kreukniet, R H van Drost, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 11, 2017
[Hip fracture in elderly patients; additional value of a multidisciplinary approach and concentration of care]
P van der Vet, J Kussen, M van Dijk, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Comparative and Functional Genomics
|
July 17, 2008
C(2)M: configurable chemical middleware
P van der Vet, H E Roosendaal, P A Geurts
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
May 1, 1988
Once daily Theo-Dur in morning dippers
A P van der Vet, M Quaedvlieg, L H Greve
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
August 1, 1984
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels
A P van der Vet, R H Drost, J Kreukniet, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
July 1, 1985
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function
A P van der Vet, J Kreukniet, R H Drost, et al.
European Journal of Respiratory Diseases. Supplement
|
January 1, 1984
Alpha 2-adrenergic receptors on intact human platelets of normal individuals and chronic obstructive lung disease patients
P L Bruynzeel, M L Hamelink, P T Kok, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1986
Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis
A P van der Vet, J Kreukniet, R H Drost, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
November 1, 1987
Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement
A P van der Vet, J Kreukniet, R H Drost, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
November 1, 1986
Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo
A P Van der Vet, J Kreukniet, R H Drost, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1987
Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis
A P van der Vet, J Kreukniet, R H van Drost, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 11, 2017
[Hip fracture in elderly patients; additional value of a multidisciplinary approach and concentration of care]
P van der Vet, J Kussen, M van Dijk, et al.
Page
of 1